Home › Pfizer Strikes Pact with Merck After Abandoning AstraZeneca
 

Keywords :   


Pfizer Strikes Pact with Merck After Abandoning AstraZeneca

2014-11-17 20:58:06| Biotech - Topix.net

Pfizer said it will pay $850 million for the rights to an experimental Merck treatment for cancer, dubbed MSB0010718C, that taps the body's anitbodies to help fight tumors. Pfizer and Darmstadt, Germany-based Merck agreed to jointly finance the further development and marketing of the drug, while Merck stands to gain up to an additional $2 billion in bonus payments depending on the treatment's success.

Tags: strikes pact merck pfizer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »